Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase

CompletedOBSERVATIONAL

Enrollment

8,804,863

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

January 16, 2025

Conditions

Adverse Effects of Medical Drugs

Interventions

DRUG

use of anticancer drugs in monotherapy or in combination therapy

ICSRs involving antineoplastic or immunomodulating agents were included.

Trial Locations (1)

Caen University Hospital, Caen

All Listed Sponsors

lead

University Hospital, Caen

OTHER

NCT06801158 - Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase | Biotech Hunter | Biotech Hunter